MiniMedvsMerck & Company

MMED and MRK stock compared: price, dividend, valuation and results, from SEC filings.

MMED

MiniMed Group, Inc.

$16.99

Value $4.8B

-4.44%
MMED's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

MiniMed (MMED) has a market value of $4.8B and Merck & Company (MRK) $341B. Dividend yield: MMED none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MMED$4.8B

    MRK$341B

    MRK is 71 times MMED

  • Revenue, 12 months

    MMED$3.2B

    MRK$67.4B

    MRK is 21 times MMED

  • Net income, 12 months

    MMED-$314M

    MRK$2.5B

  • Operating margin

    MMED-5.3%

    MRK–

  • ROIC

    MMED-3.8%

    MRK3.9%

    7.7 points apart

  • P/E

    MMED–

    MRK138.9

  • Dividend yield

    MMED0.0%

    MRK2.5%

    2.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MMED-8.1%

MRK+21.5%

75100125

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MMEDMiniMedMRKMerck & Company

Valuation

MMEDMRK
Valuation
Price$16.99$137.78
Market value$4.8B$341B
Enterprise value (EV)$4.6B$385B
P/E–138.9
P/E, 5-year median–14.8
P/B1.37.6
EV/EBIT–80.8
Free cash flow yield–4.3%

Results and growth

MMEDMRK
Results and growth
Revenue, 12 months$3.2B$67.4B
Net income, 12 months-$314M$2.5B
Free cash flow, 12 months-$316M$14.7B
Earnings per share, 12 months-$1.12$0.98
Revenue growth, year on year14.2%1.3%
Revenue growth a year, past+12.1%over 2 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

MMEDMRK
Margins and returns on capital
Gross margin53.9%71.8%
Operating margin-5.3%–
Net margin-9.8%3.6%
ROIC-3.8%3.9%
ROE-8.8%5.2%

Balance sheet

MMEDMRK
Balance sheet
Cash$207M$9.7B
Total debt$59M$53.8B
Net debt / EBITDA–5.7
Interest cover–2.4×

Dividends and buybacks

MMEDMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.5%
Shareholder yield–4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MMED or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, MiniMed or Merck & Company?

By market value, Merck & Company ($341B) is about 71.4 times MiniMed ($4.8B), at today's prices.

Which pays the higher dividend, MMED or MRK?

The dividend yield at today's price is none for MiniMed and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, MiniMed or Merck & Company?

Over the last twelve months, the net margin was -9.8% for MiniMed and 3.6% for Merck & Company, and the operating margin -5.3% and –. Revenue was $3.2B and $67.4B.

Which is the better investment, MiniMed or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.